Previous 10 | Next 10 |
Ariel Investments’ 13F portfolio value increased from $6.57B to $6.89B this quarter. They increased Gilead Sciences while reducing ViacomCBS during the quarter. The top three positions are Baidu, Philip Morris, and Microsoft and they add up to ~15% of the portfolio. F...
Elanco Animal Health (ELAN) has entered into an agreement with Kindred Biosciences (KIN) to acquire exclusive global rights to KIND-030, a monoclonal antibody being developed for canine parvovirus.Global license includes an upfront payment of $500k, development milestone payments of up t...
Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal Antibody SAN FRANCISCO , Dec. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving ...
Kindred Biosciences to Present at Guggenheim Animal Health Summit SAN FRANCISCO , Dec. 2, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr. Ric...
Kindred Biosciences (KIN) -3.2% after-hours as it discloses the suspension of its feline recombinant erythropoietin program following an "adverse event."Citing the impact of safety profile on the program's potential commercial value as well as the rapid growth of the canine dermatitis market,...
Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and A.G.P. Virtual Healthcare Symposium PR Newswire SAN FRANCISCO, Nov. 11, 2020 SAN FRANCISCO , Nov. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharma...
Kindred Biosciences, Inc. (KIN) Q3 2020 Earnings Conference Call November 09, 2020, 16:30 PM ET Company Participants Richard Chin - Co-Founder and Chief Executive Officer Wendy Wee - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners David Westenberg - ...
Kindred Biosciences (KIN): Q3 GAAP EPS of -$0.31 misses by $0.01.Revenue of $1M (-9.1% Y/Y) beats by $0.44M.Press Release For further details see: Kindred Biosciences EPS misses by $0.01, beats on revenue
Kindred Biosciences Announces Third Quarter 2020 Financial Results PR Newswire SAN FRANCISCO, Nov. 9, 2020 SAN FRANCISCO , Nov. 9, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the li...
Kindred Biosciences to Announce Third Quarter 2020 Financial Results Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time on Monday, November 9, 2020. PR Newswire SAN FRANCISCO, Oct. 28, 2020 SAN FRANCISCO , Oct. 28, ...
News, Short Squeeze, Breakout and More Instantly...
Kindred Biosciences Inc. Company Name:
KIN Stock Symbol:
NASDAQ Market:
(NewsDirect) Kin Mining NL (ASX:KIN) managing director Andrew Munckton tells Proactive significant assay results have been received from the next four lines of extensional aircore drilling between Cardinia Hill and Collymore within the Eastern Corridor at Cardinia Gold Project. He says the st...
(NewsDirect) Kin Mining NL (ASX:KIN) managing director Andrew Munckton tells Proactive all about the gold stock’s March quarter report. The explorer continued to drill and secure assays for the Cardinia Gold Project’s Helens East and Helens-Rangoon faults — pivotal prospe...
(NewsDirect) Kin Mining NL (ASX:KIN) managing director Andrew Munckton brings Proactive up to speed on the latest gold finds at the Helens-Rangoon fault within Cardinia’s Eastern Corridor. Results from a February drill program confirm that higher-grade, lode-style mineralisation extend...